GFP-SMARCA4 Citations (6)

Originally described in: Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.
Gong F, Chiu LY, Cox B, Aymard F, Clouaire T, Leung JW, Cammarata M, Perez M, Agarwal P, Brodbelt JS, Legube G, Miller KM Genes Dev. 2015 Jan 15;29(2):197-211. doi: 10.1101/gad.252189.114. PubMed Journal

---

Articles Citing GFP-SMARCA4

Articles
SCF(FBW7)-mediated degradation of Brg1 suppresses gastric cancer metastasis. Huang LY, Zhao J, Chen H, Wan L, Inuzuka H, Guo J, Fu X, Zhai Y, Lu Z, Wang X, Han ZG, Sun Y, Wei W. Nat Commun. 2018 Sep 3;9(1):3569. doi: 10.1038/s41467-018-06038-y. PubMed
Comparative RNAi Screens in Isogenic Human Stem Cells Reveal SMARCA4 as a Differential Regulator. Gunes C, Paszkowski-Rogacz M, Rahmig S, Khattak S, Camgoz A, Wermke M, Dahl A, Bornhauser M, Waskow C, Buchholz F. Stem Cell Reports. 2019 May 14;12(5):1084-1098. doi: 10.1016/j.stemcr.2019.03.012. Epub 2019 Apr 25. PubMed
Translational Diagnostics: An In-House Pipeline to Validate Genetic Variants in Children with Undiagnosed and Rare Diseases. Pijuan J, Rodriguez-Sanz M, Natera-de Benito D, Ortez C, Altimir A, Osuna-Lopez M, Roura M, Ugalde M, Van de Vondel L, Reina-Castillon J, Fons C, Benitez R, Nascimento A, Hoenicka J, Palau F. J Mol Diagn. 2021 Jan;23(1):71-90. doi: 10.1016/j.jmoldx.2020.10.006. Epub 2020 Oct 24. PubMed
SMARCA4 Depletion Induces Cisplatin Resistance by Activating YAP1-Mediated Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer. Kim J, Jang G, Sim SH, Park IH, Kim K, Park C. Cancers (Basel). 2021 Oct 30;13(21). pii: cancers13215474. doi: 10.3390/cancers13215474. PubMed
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer. He T, Cheng C, Qiao Y, Cho H, Young E, Mannan R, Mahapatra S, Miner SJ, Zheng Y, Kim N, Zeng VZ, Wisniewski JP, Hou S, Jackson B, Cao X, Su F, Wang R, Chang Y, Kuila B, Mukherjee S, Dukare S, Aithal KB, D S S, Abbineni C, Lyssiotis CA, Parolia A, Xiao L, Chinnaiyan AM. bioRxiv [Preprint]. 2024 Mar 2:2024.02.29.582768. doi: 10.1101/2024.02.29.582768. PubMed
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer. He T, Cheng C, Qiao Y, Cho H, Young E, Mannan R, Mahapatra S, Miner SJ, Zheng Y, Kim N, Zeng VZ, Wisniewski JP, Hou S, Jackson B, Cao X, Su F, Wang R, Chang Y, Kuila B, Mukherjee S, Dukare S, Aithal KB, D S S, Abbineni C, Vaishampayan U, Lyssiotis CA, Parolia A, Xiao L, Chinnaiyan AM. Proc Natl Acad Sci U S A. 2024 Apr 9;121(15):e2322563121. doi: 10.1073/pnas.2322563121. Epub 2024 Apr 1. PubMed

If you have published an article using this material, please email us at to have your article added to this page.